| Date Filed | Type | Description |
| 05/12/2023 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 20,000 options to buy
@ $0.79, valued at
$15.8k
|
|
| 03/13/2023 |
4
| Tierney David S (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 5,000 shares
@ $4.1463, valued at
$20.7k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Sold 20,000 shares
@ $14.159, valued at
$283.2k
Exercised 20,000 options to buy
@ $2.53, valued at
$50.6k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 12,000 restricted stock units
@ $0 |
|
| 12/30/2021 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $7.07, valued at
$141.4k
|
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2021 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Bought 2,000 shares
@ $7.789, valued at
$15.6k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,333 restricted stock units
@ $0 |
|
| 08/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 33,500 options to buy
@ $4.64, valued at
$155.4k
Granted 4,000 restricted stock units
@ $0 |
|
| 07/02/2019 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 6,428 shares
@ $0 |
|
| 06/14/2019 |
4
| Tierney David S (Pres and CEO) has filed a Form 4 on BioPharmX Corp|
Txns:
| Granted 360,000 options to buy
@ $0.84, valued at
$302.4k
|
|
| 05/14/2019 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 6,944 shares
@ $0 |
|
| 04/26/2019 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 12/21/2018 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.24, valued at
$56k
|
|
| 09/20/2018 |
4
| Tierney David S (CEO) has filed a Form 4 on BioPharmX Corp|
Txns:
| Bought 100,000 shares
@ $0.2025, valued at
$20.3k
|
|
| 09/13/2018 |
4
| Tierney David S (CEO) has filed a Form 4 on BioPharmX Corp|
Txns:
| Granted 7,400,000 options to buy
@ $0.22, valued at
$1.6M
|
|
| 09/13/2018 |
3
| Tierney David S (CEO) has filed a Form 3 on BioPharmX Corp |
| 05/24/2018 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/13/2017 |
4
| Tierney David S (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 7,860 shares
@ $0
Exercised 50,000 options to buy
@ $0.47, valued at
$23.5k
|
|
| 05/24/2017 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 03/21/2017 |
4
| Tierney David S (Director) has filed a Form 4 on KEMPHARM, INC |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|